# OnCo record technogenesys (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/technogenesys/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "technogenesys" ;
  schema:name "TechnoGenesys"@en ;
  schema:description "TechnoGenesys makes (R)-9b, a tablet that blocks a protein called ACK1 which helps prostate cancer keep using male hormones after standard hormone drugs stop working. It is in a first trial in men with advanced prostate cancer."@en ;
  schema:url <https://onco.cc/companies/technogenesys/>, <https://www.technogenesys.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.technogenesys.com/>, <https://www.technogenesys.com/about>, <https://clinicaltrials.gov/study/NCT06705686> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/prostate-mcrpc/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/>, <https://onco.cc/fronts/hormonal/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/> .